HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dhatariya, K. Articles by Nair, K. S. Search for Related Content PubMed PubMed Citation Articles by Dhatariya, K. Articles by Nair, K. S. Social Bookmarking                What's this?

Effect of Dehydroepiandrosterone Replacement on Insulin Sensitivity and Lipids in Hypoadrenal Women

From the Endocrine Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota

DHEA (dehydroepiandrosterone) replacement is not part of the current standard of care in hypoadrenal subjects. Animal studies have shown that DHEA administration prevents diabetes. To determine the physiological effect of DHEA replacement on insulin sensitivity in adrenal-deficient women, we performed a single-center, randomized, double-blind, placebo-controlled, crossover study in 28 hypoadrenal women (mean age 50.2 ± 2.87 years) who received a single 50-mg dose of DHEA daily or placebo. After 12 weeks, insulin sensitivity was assessed using a hyperinsulinemic-euglycemic clamp. DHEA replacement significantly increased DHEA-S (sulfated ester of DHEA), bioavailable testosterone, and androstenedione and reduced sex hormone–binding globulin levels. Fasting plasma insulin and glucagon were lower with DHEA (42 ± 4.94 vs. 53 ± 6.58 pmol/l [P = 0.005] and 178 ± 11.32 vs. 195.04 ± 15 pmol/l [P = 0.02], respectively). The average amount of glucose needed to maintain similar blood glucose levels while infusing the same insulin dosages was higher during DHEA administration (358 ± 24.7 vs. 320 ± 24.6 mg/min; P < 0.05), whereas endogenous glucose production was similar. DHEA also reduced total cholesterol (P < 0.005), triglycerides (P < 0.011), LDL cholesterol (P < 0.05), and HDL cholesterol (P < 0.005). In conclusion, replacement therapy with 50 mg of DHEA for 12 weeks significantly increased insulin sensitivity in hypoadrenal women, thereby suggesting that DHEA replacement could have a potential impact in preventing type 2 diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. S. Nair, M. L. Bigelow, Y. W. Asmann, L. S. Chow, J. M. Coenen-Schimke, K. A. Klaus, Z.-K. Guo, R. Sreekumar, and B. A. Irving Asian Indians Have Enhanced Skeletal Muscle Mitochondrial Capacity to Produce ATP in Association With Severe Insulin Resistance Diabetes, May 1, 2008; 57(5): 1166 - 1175. [Abstract] [Full Text] [PDF]

				H. Karakelides, Y. W. Asmann, M. L. Bigelow, K. R. Short, K. Dhatariya, J. Coenen-Schimke, J. Kahl, D. Mukhopadhyay, and K. S. Nair Effect of Insulin Deprivation on Muscle Mitochondrial ATP Production and Gene Transcript Levels in Type 1 Diabetic Subjects Diabetes, November 1, 2007; 56(11): 2683 - 2689. [Abstract] [Full Text] [PDF]

				R. Basu, C. Dalla Man, M. Campioni, A. Basu, K. S. Nair, M. D. Jensen, S. Khosla, G. Klee, G. Toffolo, C. Cobelli, et al. Two Years of Treatment With Dehydroepiandrosterone Does Not Improve Insulin Secretion, Insulin Action, or Postprandial Glucose Turnover in Elderly Men or Women Diabetes, March 1, 2007; 56(3): 753 - 766. [Abstract] [Full Text] [PDF]

				D. T. Villareal and J. O. Holloszy DHEA enhances effects of weight training on muscle mass and strength in elderly women and men Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1003 - E1008. [Abstract] [Full Text] [PDF]

				H. Filipsson, J. P. Monson, M. Koltowska-Haggstrom, A. Mattsson, and G. Johannsson The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3954 - 3961. [Abstract] [Full Text] [PDF]

				G. Formoso, H. Chen, J.-a Kim, M. Montagnani, A. Consoli, and M. J. Quon Dehydroepiandrosterone Mimics Acute Actions of Insulin to Stimulate Production of Both Nitric Oxide and Endothelin 1 via Distinct Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase-Dependent Pathways in Vascular Endothelium Mol. Endocrinol., May 1, 2006; 20(5): 1153 - 1163. [Abstract] [Full Text] [PDF]

				W. Arlt Androgen therapy in women Eur. J. Endocrinol., January 1, 2006; 154(1): 1 - 11. [Abstract] [Full Text] [PDF]

				Dehydroepiandrosterone (DHEA) Obstet. Gynecol., November 1, 2005; 106(5): 1096 - 1097. [Full Text] [PDF]

				S. Johnsen, S. E. Dolan, K. V. Fitch, K. M. Killilea, J. L. Shifren, and S. K. Grinspoon Absence of Polycystic Ovary Syndrome Features in Human Immunodeficiency Virus-Infected Women Despite Significant Hyperinsulinemia and Truncal Adiposity J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5596 - 5604. [Abstract] [Full Text] [PDF]